ADVANCED POLYMER SYSTEMS TO FILE NDA FOR PROZONE UVA/UVB PROTECTANT
This article was originally published in The Tan Sheet
Executive Summary
ADVANCED POLYMER SYSTEMS TO FILE NDA FOR PROZONE UVA/UVB PROTECTANT during the second quarter of 1994, the company reported on Feb. 15. The Redwood City, Calif.-based company noted that Phase III safety-in-use trials for ProZone, a prescription melanin-based UVA/UVB sun protectant, have been completed and that Phase III efficacy studies "are nearly completed." Advanced Polymer Systems said it is currently engaged in discussions with FDA "to identify and clarify any potential issues prior to the NDA filing."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning